BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34866330)

  • 1. Volumetric de-escalation and improved acute toxicity with proton craniospinal irradiation using a vertebral body-sparing technique.
    Chou B; Hopper A; Elster J; Crawford JR; McConnell K; Chang A; Mundt AJ; MacEwan I
    Pediatr Blood Cancer; 2022 May; 69(5):e29489. PubMed ID: 34866330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.
    Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL
    Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.
    Uemura S; Demizu Y; Hasegawa D; Fujikawa T; Inoue S; Nishimura A; Tojyo R; Nakamura S; Kozaki A; Saito A; Kishimoto K; Ishida T; Mori T; Koyama J; Kawamura A; Akasaka Y; Yoshida M; Fukumitsu N; Soejima T; Kosaka Y
    Cancer Med; 2022 Mar; 11(6):1502-1510. PubMed ID: 35137555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Proton Craniospinal Radiation on Vertebral Body Growth Retardation in Children.
    Ioakeim-Ioannidou M; Giantsoudi D; Niemierko A; Sethi R; Kim DW; Yock TI; Tarbell NJ; Simeone FJ; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):572-580. PubMed ID: 36055432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.
    Barney CL; Brown AP; Grosshans DR; McAleer MF; de Groot JF; Puduvalli V; Tucker SL; Crawford CN; Gilbert MR; Brown PD; Mahajan A
    Neuro Oncol; 2014 Jan; 16(2):303-9. PubMed ID: 24311638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal tissue exposure and second malignancy risk in vertebral-body-sparing craniospinal irradiation.
    Nelson B; Lamba M; Ewart S; Ike N; Lewis L; Pater L
    Med Dosim; 2022 Summer; 47(2):142-145. PubMed ID: 34996678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lifetime attributable risk of radiation-induced secondary cancer in proton craniospinal irradiation with vertebral-body-sparing for young pediatric patients with medulloblastoma.
    Suzuki S; Kato T; Murakami M
    J Radiat Res; 2021 Mar; 62(2):186-197. PubMed ID: 33341899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center.
    Chang EL; Allen P; Wu C; Ater J; Kuttesch J; Maor MH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1008-16. PubMed ID: 11958896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phantosmia during proton radiation and differences in frequency of phantosmia rates based on proton craniospinal irradiation technique for pediatric brain tumor patients.
    Ioakeim-Ioannidou M; Daartz J; Erfani P; Urell T; Lalonde A; Berv J; Leahy S; Fullerton B; Bolton R; Yock T; Tarbell N; Yeap B; MacDonald SM
    Pediatr Blood Cancer; 2024 May; 71(5):e30927. PubMed ID: 38421306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
    J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
    Brown AP; Barney CL; Grosshans DR; McAleer MF; de Groot JF; Puduvalli VK; Tucker SL; Crawford CN; Khan M; Khatua S; Gilbert MR; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):277-84. PubMed ID: 23433794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients.
    Giantsoudi D; Seco J; Eaton BR; Simeone FJ; Kooy H; Yock TI; Tarbell NJ; DeLaney TF; Adams J; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):37-46. PubMed ID: 28587051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors.
    Song S; Park HJ; Yoon JH; Kim DW; Park J; Shin D; Shin SH; Kang HJ; Kim SK; Phi JH; Kim JY
    Acta Oncol; 2014 Sep; 53(9):1158-64. PubMed ID: 24913151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.
    Hashimoto T; Shimizu S; Takao S; Terasaka S; Iguchi A; Kobayashi H; Mori T; Yoshimura T; Matsuo Y; Tamura M; Matsuura T; Ito YM; Onimaru R; Shirato H
    J Radiat Res; 2019 Jul; 60(4):527-537. PubMed ID: 31111946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated With Acute Toxicity in Pediatric Patients Treated With Proton Radiation Therapy: A Report From the Pediatric Proton Consortium Registry.
    Breen WG; Paulino AC; Hartsell WF; Mangona VS; Perkins SM; Indelicato DJ; Harmsen WS; Tranby BN; Bajaj BVM; Gallotto SL; Yock TI; Laack NN
    Pract Radiat Oncol; 2022; 12(2):155-162. PubMed ID: 34929404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
    Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
    Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
    Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
    Ho ESQ; Barrett SA; Mullaney LM
    Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
    Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.